TP53 and acute myeloid leukemia: MN-pCT exhibit a higher proportion of high risk cytogenetic abnormalities than de novo AML, particularly TP53 mutations (found in ~ 30%) and complex karyotypes, as is seen in this patient [3, 4, 26–28].